Sahirani, Nahla E.
HRN: 24-80-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2024
AMPICILLIN 1GM (VIAL)
04/30/2024
05/06/2024
IV
165mg
Q12
Acute Skin Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes